Creative Planning’s Virtus Biotech ETF BBP Stock Holding History

Creative Planning’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-200	Closed	-$8K	–	2051
2017 Q2	$8K	Hold	200	–	–	﹤0.01%	3730
2017 Q1	$8K	Hold	200	–	–	﹤0.01%	3701
2016 Q4	$7K	Hold	200	–	–	﹤0.01%	3740
2016 Q3	$7K	Hold	200	–	–	﹤0.01%	3704
2016 Q2	$5K	Hold	200	–	–	﹤0.01%	3613
2016 Q1	$5K	Hold	200	–	–	﹤0.01%	3558
2015 Q4	$6K	Sell	200 -200	-50%	-$6.06K	﹤0.01%	3567
2015 Q3	$11K	Buy	+400	New	+$13.5K	﹤0.01%	3126
2015 Q2	–	Sell	-200	Closed	-$6K	–	1266
2015 Q1	$6K	Buy	+200	New	+$5.86K	﹤0.01%	3448

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Creative Planning's BBP Position: Q3 2017 in Review

Creative Planning sold out of Virtus Biotech ETF (BBP) in Q3 2017, closing a stake of 200 shares — an estimated $8K sold.

Creative Planning first reported a position in BBP in Q1 2015 and held it in 9 quarters. The position peaked at $11K in Q3 2015. 17 funds tracked by Wall St. Rank hold BBP as of Q3 2017.

Creative Planning reported no remaining Virtus Biotech ETF position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 200 Virtus Biotech ETF shares in Q3 2017, an estimated $8K.
Creative Planning first reported a position in Virtus Biotech ETF in Q1 2015 and held it in 9 quarters.
Creative Planning's Virtus Biotech ETF position peaked at $11K in Q3 2015.
17 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.